Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Selsted
University of Southern California, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Resolve Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The funded research identified above involves defensins. Resolve Therapeutics has an option to license related technologies. Although Resolve Therapeutics' goal is to use defensins in humans, the intellectual property under study may affect the future value of the company.
Molecular Aspects of Leukocyte Antimicrobial Peptides
Naturally occurring circular peptides (theta-defensins) produced by white blood cells of monkeys have a unique ability to protect mice and rats from harmful inflammation. The mechanisms underlying this protection involve the regulation of the host's responses to a variety of noxious stimuli, and reveals that theta-defensins are endogenous anti-inflammatory molecules. In this project we will use biochemical and cellular assays and an animal model of rheumatoid arthritis to identify specific anti-inflammatory mechanisms that can be applied to the understanding and treatment of human disease.
Filed on September 26, 2013.
Tell us what you know about Michael Selsted's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Selsted filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Selsted | University of Southern California | Conflict of Interest | Oryn Therapeutics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.